Compare · AIMT vs NEOS
AIMT vs NEOS
Side-by-side comparison of Aimmune Therapeutics, Inc. (AIMT) and Neos Therapeutics, Inc. (NEOS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AIMT and NEOS operate in Major Pharmaceuticals (Health Care), so they compete in similar markets.
- Company
- Aimmune Therapeutics, Inc.
- Neos Therapeutics, Inc.
- Price
- -
- -
- Market cap
- -
- -
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Major Pharmaceuticals
- Major Pharmaceuticals
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2015
- 2015
- News (4w)
- 0
- 0
- Recent ratings
- 0
- 0
Latest AIMT
- SEC Form SC 13G/A filed
- Monteverde & Associates PC Files Class Action Lawsuit On Behalf Of Shareholders Of Aimmune Therapeutics, Inc. In The Northern District Of California
- Nestlé completes acquisition of Aimmune Therapeutics
- Nestlé announces results of tender offer for Aimmune Therapeutics, Inc.
- Nestlé announces results of tender offer for Aimmune Therapeutics, Inc.
- Life-Saving Advancements, Treatments Delivered by Companies Invested in Innovation
- ALERT: Halper Sadeh LLP Is Investigating the Following Mergers; Shareholders are Encouraged to Contact the Firm
- Lifshitz Law Firm, P.C. Announces Investigation of Aimmune Therapeutics, Inc., (NASDAQ:AIMT), Akcea Therapeutics, Inc., (NASDAQ:AKCA), BMC Stock Holdings, Inc., (NASDAQ:BMCH), and Cancer Genetics, Inc., (NASDAQ:CGIX)
- Nestlé commences tender offer for Aimmune Therapeutics, Inc.
- Nestlé commences tender offer for Aimmune Therapeutics, Inc.
Latest NEOS
- FDA Approval for COTEMPLA XR-ODT issued to NEOS THERAPS INC
- FDA Approval for COTEMPLA XR-ODT issued to NEOS THERAPS INC
- SEC Form EFFECT filed by Neos Therapeutics, Inc.
- SEC Form EFFECT filed by Neos Therapeutics, Inc.
- SEC Form EFFECT filed by Neos Therapeutics, Inc.
- SEC Form EFFECT filed by Neos Therapeutics, Inc.
- SEC Form 8-K filed by Neos Therapeutics, Inc.
- SEC Form 425 filed by Neos Therapeutics, Inc.
- SEC Form 4: M John Limongelli disposed to the issuer $0 worth of Common Stock (83,015 units at $0.00), decreasing direct ownership by 100% to 0 units
- SEC Form 4: Jr. A. James Robinson disposed to the issuer $0 worth of Common Stock (23,453 units at $0.00), decreasing direct ownership by 100% to 0 units